The COVID-RASi Trial (COVID-19)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Liu, MD
Ottawa Heart Institute Research Corporation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centro de Pesquisa Clinicas Dr Marco Mota
Maceió, Alagoas, Brazil
- Centro de Pesquisas Em Diabetes E Doencas Endocrino-Metabolicas
Fortaleza, Ceará, Brazil
- Santa Casa de Itabuna
Itabuna, Estado de Bahia, Brazil
- Hospital Felicio Rocho
Belo Horizonte, Minas Gerais, Brazil
- Centro de Pesquisa Clinica Da Unimed Campo Grande
Campo Grande, Minas Gerais, Brazil
- Clinica de Campo Grande
Campo Grande, Minas Gerais, Brazil
- Nucleo de Pesquisa Clinica Ss
Curitiba, Paraná, Brazil
- Hospital Agamenom Magalhaes
Recife, Pernambuco, Brazil
- Pronto Socorro Cardiologico de Pernambuco Recife
Recife, Pernambuco, Brazil
- Hospital Eduardo Campos Da Pessoa Idosa
Estância, Recife, Brazil
- Instituto Atena de Pesquisa Clinica
Natal, Rio Grande do Norte, Brazil
- Hospital Universitar Canoas
Canoas, Rio Grande do Sul, Brazil
- Hospital Sao Vicente de Paulo
Passo Fundo, Rio Grande do Sul, Brazil
- Hospital Sao Lucas Da Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
- Hospital Universitario Sao Francisco Na Providencia de Deus
Bragança Paulista, São Paulo, Brazil
- Instituto de Pesquisa Clinica de Campinas
Campinas, São Paulo, Brazil
- Hospital Bela Vista
Consolação, São Paulo, Brazil
- Hospital de Julho
São Paulo, São Paulo, Brazil
- Instituto Prevent Senior
São Paulo, São Paulo, Brazil
- Instituto de Coracao
São Paulo, São Paulo, Brazil
- Instituto Goiano de Oncologia E Hematologia
Goiânia, Brazil
- Alberta Health Services
Edmonton, Alberta, Canada
- University of Ottawa Heart Institute
Ottawa, Ontario, Canada
- Hospital de Infectologia Dr Daniel Mendez Fernandez
Azcapotzalco, Mexico City, Mexico
- Hospital General de Zona 20
La Margarita, Puebla, Mexico
- Hospital General Regional No 2
El Marqués, Querétaro, Mexico
- Unidad de Medicina Familiar No 77
Ecatepec de Morelos, State of Mexico, Mexico
- Hospital General Zona 11
Xalapa, Veracruz, Mexico
- Unidad de Medicina Familiar No 10
Xalapa, Veracruz, Mexico
- Hospital General 1, Imss
Mexico City, Mexico
- Hospital General de Zona 27- Imss
Mexico City, Mexico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jan 2021
- Primary completion
- 30 Dec 2024
- Completion
- 30 Dec 2024
- Last update posted
- 28 Jan 2026
- Registered enrollment
- 372
- Registry id
- NCT04591210
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.